# Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes

> **NCT06989697** · PHASE3 · RECRUITING · sponsor: **Seoul National University Bundang Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Type 2 Diabets Mellitus
- Cognitive Ability, General

## Interventions

- **DRUG:** Cilostazol / Ginko Leaf Dried Ext.
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06989697
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06989697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06989697, "Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06989697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*